David Fivenson, MD, PLC /ID# 210193

Ann Arbor, Michigan 48103

0 studies enrolling now · 1 studies all time

What they study most

Psoriasis

Studies at this site

• A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis — Completed